• AJMCAJMC
  • Center for Biosimilars
The Center for Biosimilars - Biosimilars, Health Economics & Insights
The Center for Biosimilars - Biosimilars, Health Economics & Insights
Business Practice
View MoreBusinessDevelopmentLegalPolicyPracticeRegulatory
News
All News
Product Approvals and Launches
Media
All Videos
Insights
Interviews
Peer Exchange
Podcasts
Stakeholder Summit
Conferences
Conference Coverage
Conference Listing
CME/CE
Resources
Authors
Biosimilar Resources
Interactive Tools
Partners
Polls and Quizzes
Sponsored
WHEN CHOICE ARRIVES: Competition & Consequences
SubscribeBIOSIMILAR APPROVALS
  • About
  • Contact
  • Advisory Board
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

© 2026 MJH Life Sciences and The Center for Biosimilars - Biosimilars, Health Economics & Insights. All rights reserved.

Advertisement
Business PracticeSee All >
  • Business
  • Development
  • Legal
  • Policy
  • Practice
  • Regulatory
  • About
  • Contact
  • Advisory Board
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy
  • MJHLS Brand Logo

© 2026 MJH Life Sciences™ and The Center for Biosimilars - Biosimilars, Health Economics & Insights. All rights reserved.

Regulation, Policy, and Litigation in Biosimilars

EP. 1: Biosimilar Interchangeability and Market Share

October 30th 2017

EP. 2: Interchangeability and Rheumatology Prescribing Practices

October 30th 2017

EP. 3: Biosimilars, Interchangeability, and Perceptions of Safety

October 30th 2017

EP. 4: Global Reference Products in Biosimilar Development

October 30th 2017

EP. 5: Inspection Reports and Proprietary Information

October 30th 2017

EP. 6: Reforms at the FDA Level

October 30th 2017

EP. 7: Biosimilars, Formularies, Contracting, and PBMs

October 30th 2017

EP. 8: Biosimilar Uptake and Health Plans

October 30th 2017

EP. 9: CMS and Blended Reimbursement Codes

October 30th 2017

EP. 10: Healthcare Reform Efforts and the BPCIA

October 30th 2017

Advertisement
Advertisement